Latest Announcements

Statement on Form 483 at the Ankleshwar API plant

20 Feb 2017 | Read More

Glenmark’s Q3 FY 17 results

2 Feb 2017 | Read More

Glenmark’s MDA Q3 FY 17

2 Feb 2017 | Read More

Glenmark’s consolidated revenue increases by 42.55 % to Rs. 25,350.08 Mn for Q3 FY 2016 – 17

2 Feb 2017 | Read More

J P Morgan Healthcare Conference – presentation

30 Jan 2017 | Read More

Intimation regarding board meeting

17 Jan 2017 | Read More

Statement of Investor Complaints for Q3 (F. Y. 2016-17)

11 Jan 2016 | Read More

Webcast of analyst and investor meet 2016

29 Dec 2016 | Read More

Strategic Blueprint for the Next Decade – Investor presentation

19 Dec 2016 | Read More

Strategic Blueprint for the Next Decade – Media presentation

19 Dec 2016 | Read More

Glenmark's Q2 FY17 Result Balance Sheet

2 Nov 2016 | Read More

Glenmark's MDA Q2 FY 2017

2 Nov 2016 | Read More

Glenmark’s consolidated revenue increases by 16.48% to Rs. 22241.09 Mn for Q2 FY 2016 – 17

2 Nov 2016 | Read More

Reconciliation of Share Capital Audit Report

10 Oct 2016 | Read More

Compliance Certificate under Regulation 7(3)

10 Oct 2016 | Read More

Certificate from Practicing Company Secretary under Regulation 40(9)

10 Oct 2016 | Read More

Statement of Investor Complaints for Q2

10 Oct 2016 | Read More

Shareholding Pattern for Q2

10 Oct 2016 | Read More

Corporate Governance Report for Q2

10 Oct 2016 | Read More

38th AGM Proceedings

12 Aug 2016 | Read More

38th AGM Notice – The Free Press Journal

21 Jul 2016 | Read More

38th AGM Notice – Navshakti

21 Jul 2016 | Read More

Glenmark e-voting notice

19 Jul 2016 | Read More

Glenmark notice proxy form

19 Jul 2016 | Read More

Annual report FY 2016

19 Jul 2016 | Read More

Intimation to the exchange

18 Jul 2016 | Read More

Statement of Investor Complaint

13 Jul 2016 | Read More

Reconciliation Share Capital

30 Jun 2016 | Read More

Q4 Shareholding Pattern

30 Jun 2016 | Read More

Corporate governance website

30 Jun 2016 | Read More

Approval of Subscription Agreement for FCCB's

31 May 2016 | Read More

Q4 - Statement of Investor Complaints

7 Apr 2016 | Read More

Q4 - Reconciliation Share Capital

31 Mar 2016 | Read More

Q4 - Format of Holding of specified securities (2)

31 Mar 2016 | Read More

Q4 - Format of Holding of specified securities

31 Mar 2016 | Read More

Cancellations of ESOP Options

28 Jan 2016 | Read More

Authorised KMP for Disclosure of Materality of Events or Information

28 Jan 2016 | Read More

Glenmark JPMorgan 2016

15 Jan 2016 | Read More

About Us

Leading, integrated, global, research-led organization. Words which define us and our vision to discover a healthier future
Know More